# Executive Order Analysis: restoring-gold-standard-science

ğŸ“… **Date:** 2025-05-23  
ğŸ”— **Original Executive Order:** [View on WhiteHouse.gov](https://www.whitehouse.gov/presidential-actions/2025/05/restoring-gold-standard-science/)

---

Below is the detailed analysis of the executive order based on the requested framework.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
1ï¸âƒ£ Summary & Intent

â€¢ Summary: This executive order sets out to â€œrestoreâ€ what the administration terms â€œGold Standard Scienceâ€ across federal agencies. Its stated purpose is to reestablish rigorous, transparent, reproducible, and unbiased scientific practices within government decision-making.  
â€¢ Key Provisions: 
â€ƒ â€“ Mandates the OSTP Director, in consultation with agency heads, to issue guidance on â€œGold Standard Scienceâ€ within 30 days.  
â€ƒ â€“ Requires agencies to update and, if necessary, rescind scientific integrity policies and procedures adopted since January 20, 2021.  
â€ƒ â€“ Imposes rigorous requirements for data transparency, disclosure of model assumptions, explicit communication of uncertainty, and internal oversight on the use and reporting of scientific information.  
â€ƒ â€“ Reverses or nullifies changes made under the prior administration (such as the incorporation of diversity, equity, and inclusion considerations into science planning).  
â€¢ Modifications/Reversions: The order explicitly directs agencies to revert to policies that predate January 20, 2021 if there is any conflict with its requirements.  
â€¢ Impact on Key Areas: Although not directly targeting health care, education, childcare, or housing, the order is partly justified by its commentary on past COVIDâ€19 guidance for school reopenings. Its emphasis on â€œaccurateâ€ scientific information could affect future policy decisions in the public health and education sectors, indirectly influencing decisions that shape access to educational environments and public health options.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
2ï¸âƒ£ Fact-Checking & Factual Basis

â€¢ Key Claims Identified:
â€ƒ â€“ That scientific confidence has declined due to reproducibility issues and data falsification in federally funded research.
â€ƒ â€“ Specific instances, such as the COVID-19 reopening guidance and the use of worst-case scenarios in environmental and climate assessments, are cited as examples of misleading practices.
â€¢ Assessment of Claims:
â€ƒ â€“ Issues with reproducibility and isolated cases of data falsification in some scientific fields are documented in academic literature; however, the portrayal of these issues as widespread and the causative role attributed to past administrations is partly true but also politically charged.
â€ƒ â€“ The claim regarding edited COVID-19 guidance affecting school reopenings has elements of truth (i.e., debates have occurred over the balance between caution and overreach) but is subject to differing interpretations based on evolving scientific evidence.
â€ƒ â€“ References to worst-case scenario models (e.g., in fisheries or climate change) reflect genuine debates in scientific circles, though the context in which they are presented remains contentious.
â€¢ Overall: The orderâ€™s central factual assertions are partly true but also selectively presented, with certain examples being used to support a political narrative rather than a fully balanced assessment. (Rating: Mostly True/Partly True)

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
3ï¸âƒ£ Constitutionality & Legal Precedents

â€¢ Alignment with Constitutional Principles:
â€ƒ â€“ The order is grounded in the presidentâ€™s authority to direct executive branch operations, relying on statutory powers (e.g., 5 U.S.C. Â§7301).  
â€ƒ â€“ It primarily sets administrative policy regarding the use and communication of scientific data and evidence, which generally falls within executive discretion.
â€¢ Legal Precedents & Potential Challenges:
â€ƒ â€“ Similar executive orders on science and evidence-based policymaking have been issued by prior administrations, though reversals of existing policies (particularly those that incorporate diverse perspectives) may provoke legal and political challenges.
â€ƒ â€“ Possible conflicts could arise under statutes like the Administrative Procedure Act if agencies claim that required policy reversals or expedited changes undermine established rules.
â€ƒ â€“ Courts have historically deferred to executive discretion on matters of administrative organizationâ€”as long as the order does not infringe on rights beyond the executiveâ€™s purviewâ€”yet criticisms about politicizing science might fuel future litigation.
â€¢ Relevant Opinions: Past Supreme Court decisions have generally supported broad executive authority over agency management (while setting limits concerning delegation and transparency), meaning that while the order is likely legally sound, its implementation could be scrutinized for potential overreach.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
4ï¸âƒ£ National Stability & Institutional Trust

â€¢ Public Confidence: By emphasizing a â€œgold standardâ€ of transparency and rigor, the order aims to restore public trust in federally funded research and government decision-making. However, its selective reversal of policies (notably those embracing diversity and inclusion) may raise concerns among communities that benefited from the prior administrationâ€™s approach.  
â€¢ Civil Unrest Risks: The orderâ€™s politically charged language and its targeting of practices from the previous administration could deepen partisan divisions. Whereas some may applaud the recommitment to scientific rigor, others may view this as an overcorrection that undermines inclusive, evidence-based policymaking.
â€¢ Democratic Integrity & Rule of Law: Although the order reinforces internal checks regarding scientific claims (e.g., requiring transparency and peer review), its directive to rescind policies implemented over the past four years raises potential questions about the balance between executive authority and the independent functioning of agencies. In this respect, it risks setting a precedent perceived by critics as encouraging further executive overreach in areas traditionally managed by independent scientific communities.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
5ï¸âƒ£ Harm & Impact Assessment

â€¢ Direct Harm: There is minimal direct infringement on individual rights; however, by directing agencies to favor specific methodologies and to retrospectively nullify policy changes, the order could indirectly affect how scientific findings are translated into public policyâ€”potentially disadvantaging communities that rely on nuanced interpretations of data (for example, in public health guidance or educational policy).
â€¢ Legal Harm: The order may contribute to institutional uncertainty if agencies are forced into abrupt policy reversals. This disruption could impair the continuity of data-driven decision processes, thereby weakening due process and the established norms of administrative law.
â€¢ Economic Harm: While the order intends to spur innovation and maintain global leadership in technology, disruptive changes in governance could lead to hesitancy among researchers and businesses that depend on stable, consistent regulatory frameworks.
â€¢ Environmental & Global Stability: Its emphasis on dismissing â€œoverly precautionaryâ€ or worst-case assumptions might limit the adoption of policies that are cautious with respect to environmental risks. This could have downstream effects on climate policy, although the order does not directly target environmental regulation.
â€¢ Social Equity & Progressive Values: Critically, the orderâ€™s mandated rollback of policies that integrated diversity, equity, and inclusion into scientific decision-making signals a retreat from progressive priorities. This reversion may adversely affect areas such as educational policy (e.g., safe school reopenings under transparent scientific guidance) and public healthâ€”potentially narrowing rather than expanding access to the informed, science-based policies that underpin free access to health care and education.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
6ï¸âƒ£ Policy in Real Life: Individual Impact

Consider the story of Maria, an experienced high school science teacher in a mid-sized city. Last year, Maria experienced firsthand the negative effects of inconsistent scientific guidance during the COVID-19 pandemic. School reopening plans were suspended for extended periods after policymakers relied on worst-case scenario models and guidance that did not transparently communicate their underlying uncertainties. Her students, many of whom struggled at home without proper access to in-person instruction, suffered setbacks in both educational achievement and social-emotional well-being. For Maria, the clarity and transparency in scientific reporting are not abstract principles but essential ingredients in securing a safe learning environment for her pupils.

With this new executive order in effect, Maria hopes that requiring federal agencies to adopt â€œGold Standard Scienceâ€ will bring about a renewed commitment to rigorous, evidence-based policymaking. However, she is also concerned that the orderâ€™s rollback of initiatives that promoted inclusive and diverse perspectives in scientific assessments could ignore the lived realities of many community members. While the order promises to reestablish trust in government-supported science, its selective focus â€“ especially the reversal of progressive policies that had helped guide equitable public health and educational decisions â€“ risks sidelining the very voices that need to be heard. For families relying on transparent, scientifically informed policies in education and health care, the orderâ€™s ambiguous legacy may offer as many questions as promises for the future.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
7ï¸âƒ£ Final Scoring (-5 to +5 in each category)

â€¢ Fact-Checking Score: +2  
â€ƒ â€“ Several claims are partly based on factual challenges within scientific practices; however, the selective presentation of examples skews the overall narrative.

â€¢ Constitutionality Score: +3  
â€ƒ â€“ The order largely falls within the presidentâ€™s statutory authority for managing executive branch operations, though its targeted reversals may prompt legal debates.

â€¢ National Stability Score: +1  
â€ƒ â€“ Although it seeks to restore trust by emphasizing rigorous science, its politically charged reversals could contribute to partisan polarization.

â€¢ Harm Score: -1  
â€ƒ â€“ While aiming for better scientific decision-making, its potential disruption to established scientific policy processes and rollback of progressive safeguards could generate negative outcomes.

â€¢ Progressive Values Score: -3  
â€ƒ â€“ By rescinding policies that embraced diversity, equity, and inclusion in scienceâ€”and that informed more balanced approaches to public health and educationâ€”the order may undermine efforts to ensure free access to quality education and health-related policies.

Aggregate Score Calculation: +2 +3 +1 -1 -3 = +2  
Interpretation: With an aggregate score of +2, the overall impact of the executive order falls within the â€œNeutral or Unclear Impactâ€ range. While the order may bolster a commitment to transparent, reproducible science, its politicized retrenchment of progressive policies creates uncertainties regarding its benefits for social equity and related public interests.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
8ï¸âƒ£ Action & Mobilization

âœ‰ï¸ Letter to Congress  
Dear [Representativeâ€™s Name],

I am writing to express my profound concerns regarding the recently issued executive order mandating a rollback of scientific integrity policies adopted over the past several years. While ensuring rigorous and transparent scientific research is essential to good governance, the decision to reverse established diversity, equity, and inclusion measuresâ€”and the selective targeting of policies that informed critical issues such as COVID-19 school reopening guidanceâ€”risks undermining the progress we have made in public education and health care. Such a move could inadvertently jeopardize the credibility of federal science, further polarize public debates, and negatively impact communities that rely on evidence-based policies to safeguard their well-being.

I urge you to oppose this executive order and work with your colleagues to ensure that our nationâ€™s scientific research remains both rigorous and inclusive. Restoring public trust in scientific institutions should not come at the expense of disregarding progressive values that ensure free access to quality education, health care, and social equity. In a time when clear, transparent, and balanced information is critical to our nationâ€™s future, I ask that you stand up against policies that threaten to narrow the perspectives necessary for sound public policy decisions.

Sincerely,  
[Senderâ€™s Name]

ğŸ“¢ Social Media Posts for Mobilization

â€¢ Twitter/X: "This new executive order weakens inclusive, scienceâ€based policymakingâ€”threatening our progress in education and public health. Urge your rep to oppose it! #ProtectScience #InclusivePolicy"
â€¢ Facebook: "Our voices matter! This executive order jeopardizes vital policies that have helped ensure fairness in education and public health by reversing inclusive science reforms. Email your Congressperson now to demand they oppose these harmful changes. #ProgressNotPolitics #TransparentScience"
â€¢ Instagram: "ğŸ“¢ Stand up for inclusive, evidence-based policies! This order could roll back progress in education and health care by targeting diversity and inclusion in science. Send a letter to your rep today! (Link in bio) #ActNow #EquityInScience"
â€¢ LinkedIn: "Sound science is the foundation of a healthy democracy. However, this new executive order undermines progressive policies that ensured transparent and inclusive scientific practicesâ€”critical to informed decisions in education and public health. Join me in urging Congress to oppose this setback. #PolicyMatters #InclusiveScience"

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ğŸ” Final Verdict & Takeaways

This executive order is a mixed bag. On one hand, it champions a return to stringent standards for scientific data and transparency, promising to enhance the credibility of federal research and ultimately improve decision-making. On the other hand, its politically motivated reversal of initiatives that embraced diversity, equity, and inclusion risks undercutting progressive aimsâ€”particularly those linked to informed public health and education policies.

Key risks include legal challenges regarding abrupt policy reversals, potential erosion of inclusive scientific practices, and increased partisan polarization. Although the order seeks to reestablish trust in government science, its selective rollback of measures that helped ensure equitable access to robust, science-based policy outcomesâ€”such as those affecting education and public healthâ€”could have lasting impacts on communities that depend on those protections. Citizens and progressives are encouraged to engage their representatives now to ensure that while we maintain rigorous scientific standards, we do not sacrifice the inclusive policies that secure free access to quality education, health care, and a fair society.



---

## âœï¸ Contact A Nevada Representative

### Senator Catherine Cortez Masto (D)
|                         |              |
| ---                     | ---          |
|[Online Contact Page](https://www.cortezmasto.senate.gov/contact/connect/) | |
| Reno Office Number      | 775-686-5750 |
| Las Vegas Office Number | 702-388-5030 |
| D.C Number              | 202-224-7327 |

### Senator Jacky Rosen (D)
|                         |              |
| ---                     | ---          |
|[Online Contact Page](https://www.rosen.senate.gov/email-jacky/) | |
| Reno Office Number      | 775-337-0110 |
| Las Vegas Office Number | 702-388-0205 |
| D.C Number              | 202-224-6244 |

### Congresswoman Dina Titus (D) - NV District 1
|                         |              |
| ---                     | ---          |
|[Online Contact Page](https://titus.house.gov/contact/) | |
| Las Vegas Office Number | 702-220-9823 |
| D.C Number              | 202-225-5965 |

### Congressman Mark Amodei (R) - NV District 2
|                         |              |
| ---                     | ---          |
|[Online Contact Page](https://amodei.house.gov/address_authentication?form=/email-me) | |
| Reno Office Number      | 775-686-5760 |
| Elko Office Number      | 775-777-7705 |
| D.C Number              | 202-225-6155 |

### Congresswoman Susie Lee (D) - NV District 3
|                         |              |
| ---                     | ---          |
|[Online Contact Page](https://susielee.house.gov/address_authentication?form=/contact) | |
| Las Vegas Office Number | 702-963-9336 |
| D.C Number              | 202-225-3252 |

### Congressman Steven Horsford (D) - NV District 4
|                         |              |
| ---                     | ---          |
|[Online Contact Page](https://horsford.house.gov/address_authentication?form=/contact) | |
| Las Vegas Office Number | 702-963-9360 |
| D.C Number              | 202-225-9894 |

